Evonik Industries’ (EVK) Neutral Rating Reaffirmed at Goldman Sachs Group
Goldman Sachs Group reiterated their neutral rating on shares of Evonik Industries (FRA:EVK) in a research note issued to investors on Monday, Borsen Zeitung reports.
A number of other research analysts have also recently issued reports on the stock. Berenberg Bank reaffirmed a buy rating and issued a GBX 340 ($4.44) price target on shares of Stock Spirits Group in a report on Tuesday, May 14th. UBS Group cut shares of CR AGRICOLE S A/ADR from a buy rating to a neutral rating in a report on Monday, May 20th. Sanford C. Bernstein set a €68.00 ($79.07) price target on shares of Basf and gave the stock a neutral rating in a report on Tuesday, June 25th. JPMorgan Chase & Co. raised their price target on shares of from GBX 2,300 ($30.05) to GBX 2,900 ($37.89) and gave the stock a neutral rating in a report on Friday, July 5th. Finally, Warburg Research set a €60.00 ($69.77) price target on shares of Compugroup Medical and gave the stock a neutral rating in a report on Tuesday, May 7th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus price target of €30.90 ($35.93).
Shares of FRA EVK traded down €0.30 ($0.35) during midday trading on Monday, reaching €24.93 ($28.99). The company had a trading volume of 760,672 shares. The company’s 50-day moving average is €24.83. Evonik Industries has a 1 year low of €26.78 ($31.14) and a 1 year high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Further Reading: What is a bull market?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.